about
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include S...
Read More
0.47
0.04
(9.30%)
20.5M
XNAS Volume
XNAS 03 Mar, 2026 4:30 PM (EST)
Board Meeting
The next board meeting for Gossamer Bio Inc is on 13 Mar 2026 for the purpose of Gossamer Bio Inc Annual Report for 2025
See details
Not Eligible
Expensive Valuation
Technically Bearish
Gossamer Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..